Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 8 | 2024 | 2254 | 1.730 |
Why?
|
| Serum Albumin | 4 | 2024 | 674 | 1.660 |
Why?
|
| Anemia | 2 | 2023 | 1504 | 0.870 |
Why?
|
| Dialysis Solutions | 1 | 2022 | 34 | 0.810 |
Why?
|
| Hypertension, Pulmonary | 3 | 2018 | 1592 | 0.810 |
Why?
|
| Uremia | 1 | 2022 | 202 | 0.740 |
Why?
|
| Kidney Failure, Chronic | 5 | 2024 | 2478 | 0.710 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 5842 | 0.500 |
Why?
|
| Syncope | 1 | 2017 | 428 | 0.450 |
Why?
|
| Blood Glucose | 2 | 2023 | 6392 | 0.370 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 15521 | 0.370 |
Why?
|
| Citrulline | 1 | 2024 | 107 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2016 | 2597 | 0.230 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 2571 | 0.210 |
Why?
|
| Charcoal | 1 | 2022 | 67 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2016 | 2889 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2016 | 4479 | 0.180 |
Why?
|
| Renal Dialysis | 2 | 2022 | 1796 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12159 | 0.160 |
Why?
|
| Glycosylation | 1 | 2022 | 1095 | 0.160 |
Why?
|
| Digestive System Neoplasms | 1 | 2019 | 83 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 2 | 2023 | 2182 | 0.140 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 11476 | 0.140 |
Why?
|
| Glycemic Index | 1 | 2019 | 396 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2016 | 565 | 0.120 |
Why?
|
| Aortic Valve Stenosis | 2 | 2018 | 2018 | 0.120 |
Why?
|
| Humans | 21 | 2024 | 761222 | 0.120 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 891 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 1967 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2024 | 2092 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2024 | 41496 | 0.100 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 1039 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1504 | 0.100 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2015 | 345 | 0.090 |
Why?
|
| Cause of Death | 2 | 2018 | 3688 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1182 | 0.080 |
Why?
|
| Disease Progression | 2 | 2023 | 13511 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1031 | 0.080 |
Why?
|
| Proteins | 1 | 2022 | 5993 | 0.070 |
Why?
|
| Health Surveys | 1 | 2016 | 4037 | 0.070 |
Why?
|
| China | 3 | 2018 | 2374 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2016 | 6345 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15841 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20118 | 0.060 |
Why?
|
| Echocardiography | 1 | 2016 | 5006 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2018 | 8479 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 4242 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 54437 | 0.050 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2022 | 19 | 0.050 |
Why?
|
| Aged | 7 | 2024 | 169292 | 0.050 |
Why?
|
| Diet | 1 | 2019 | 8048 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 611 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8536 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 220858 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 989 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 3899 | 0.040 |
Why?
|
| Male | 7 | 2024 | 360703 | 0.030 |
Why?
|
| Prognosis | 3 | 2024 | 29688 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 10707 | 0.030 |
Why?
|
| Platelet Count | 1 | 2018 | 782 | 0.030 |
Why?
|
| Female | 6 | 2024 | 392552 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15637 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 735 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 1725 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1381 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 74241 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 416 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 1751 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2024 | 24022 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1664 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 12474 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2022 | 5103 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2022 | 5521 | 0.020 |
Why?
|
| Mortality | 1 | 2016 | 2896 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 58952 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12052 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1923 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5295 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2018 | 80675 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13249 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10516 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10218 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64681 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22174 | 0.010 |
Why?
|
| Stroke | 1 | 2016 | 9721 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 59222 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 88300 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 221120 | 0.000 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_